Comerica Bank
AMRI

Comerica Bank’s Albany Molecular Research Inc AMRI Stock Holding History

Comerica Bank’s Portfolio AMRI Stock Details AMRI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q3 		– Sell
-24,023
Closed -$521K – 2282
2017
Q2 		$521K Sell
24,023
-1,459
-6% -$26.5K ﹤0.01% 1824
2017
Q1 		$422K Buy
25,482
+542
+2% +$8.88K ﹤0.01% 1931
2016
Q4 		$452K Buy
24,940
+1,349
+6% +$22.9K ﹤0.01% 1899
2016
Q3 		$407K Sell
23,591
-3,586
-13% -$53.1K ﹤0.01% 1852
2016
Q2 		$422K Sell
27,177
-479
-2% -$6.99K ﹤0.01% 1844
2016
Q1 		$453K Buy
27,656
+18
+0.1% +$282 ﹤0.01% 1793
2015
Q4 		$492K Buy
27,638
+217
+0.8% +$4.12K ﹤0.01% 1721
2015
Q3 		$478K Sell
27,421
-22,159
-45% -$451K ﹤0.01% 1731
2015
Q2 		$1M Buy
49,580
+25,687
+108% +$496K ﹤0.01% 1768
2015
Q1 		$420K Sell
23,893
-22,827
-49% -$389K ﹤0.01% 1813
2014
Q4 		$760K Buy
46,720
+23,509
+101% +$431K ﹤0.01% 1841
2014
Q3 		$512K Buy
23,211
+4,555
+24% +$93.3K ﹤0.01% 1764
2014
Q2 		$375K Buy
+18,656
New +$316K ﹤0.01% 1881

Other funds holding AMRI

AA
Ancora Advisors Cleveland, Ohio $4.7B AUM 19.05% 1-Year Est. Return
DekaBank Deutsche Girozentrale
DekaBank Deutsche Girozentrale Frankfurt, Germany $60.6B AUM 23.27% 1-Year Est. Return

Comerica Bank's AMRI Position: Q3 2017 in Review

Comerica Bank sold out of Albany Molecular Research Inc (AMRI) in Q3 2017, closing a stake of 24,023 shares — an estimated $521K sold.

Comerica Bank first reported a position in AMRI in Q2 2014 and held it in 13 quarters. The position peaked at $1M in Q2 2015. 2 funds tracked by Wall St. Rank hold AMRI as of Q3 2017.

  • Comerica Bank reported no remaining Albany Molecular Research Inc position as of Q3 2017 after selling out during the quarter.
  • Comerica Bank sold 24,023 Albany Molecular Research Inc shares in Q3 2017, an estimated $521K.
  • Comerica Bank first reported a position in Albany Molecular Research Inc in Q2 2014 and held it in 13 quarters.
  • Comerica Bank's Albany Molecular Research Inc position peaked at $1M in Q2 2015.
  • 2 funds tracked by Wall St. Rank held Albany Molecular Research Inc as of Q3 2017.

Based on Comerica Bank's 13F filing for Q3 2017, filed 6 Nov 2017.